Cargando…
Roadmap for new practitioners to navigate the multiple myeloma landscape
Multiple myeloma (MM) is a blood cancer in which monoclonal plasma cells cause end organ damage resulting in hypercalcemia, renal failure, anemia, and bone lesions. MM is considered incurable, however, recent advances in treatment have improved survival. Historically, MM has been treated with immuno...
Autores principales: | Tam, Tiffany, Smith, Eric, Lozoya, Evelyn, Heers, Hayley, Andrew Allred, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508512/ https://www.ncbi.nlm.nih.gov/pubmed/36164513 http://dx.doi.org/10.1016/j.heliyon.2022.e10586 |
Ejemplares similares
-
Navigating the treatment landscape in multiple myeloma: which combinations to use and when?
por: Goldschmidt, Hartmut, et al.
Publicado: (2018) -
S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA
por: Ramberger, Evelyn, et al.
Publicado: (2023) -
Navigating inequities: a roadmap out of the pandemic
por: Ismail, Shainoor J, et al.
Publicado: (2021) -
Navigating and expanding the roadmap of natural product genome mining tools
por: Biermann, Friederike, et al.
Publicado: (2022) -
The Change Leader's Roadmap: How to Navigate Your Organization's Transformation
por: Anderson, Linda
Publicado: (2010)